These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3516580)

  • 1. Fenoverine: smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation.
    Camarri E
    Curr Med Res Opin; 1986; 10(1):52-7. PubMed ID: 3516580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenoverine: a two-step, double-blind and open clinical assessments of its smooth muscle synchronizing effects.
    Bader F
    Pharmatherapeutica; 1986; 4(7):422-8. PubMed ID: 3515369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of fenoverine and trimebutine in the management of irritable bowel syndrome: multicenter randomized double-blind non-inferiority clinical study].
    Kang SH; Jeen YT; Koo JS; Koo YS; Kim KO; Kim YS; Kim SY; Moon JS; Park JJ; Baek IH; Park SC; Lee SJ; Lee JH; Choung RS; Choi SC
    Korean J Gastroenterol; 2013 Nov; 62(5):278-87. PubMed ID: 24262593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A three-part controlled study of trimebutine in the treatment of irritable colon syndrome.
    Lüttecke K
    Curr Med Res Opin; 1980; 6(6):437-43. PubMed ID: 6988171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in irritable colon. II. Repeated oral administration].
    Galeone M; Benazzi E; Bossi M; Moise G; Riva A; Stock F
    Pharmatherapeutica; 1986; 4(8):496-509. PubMed ID: 3714757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of trimebutine in spastic colon.
    Lüttecke K
    J Int Med Res; 1978; 6(2):86-8. PubMed ID: 344090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled evaluation of a new synthetic spasmolytic (DA 3177) in/pathology of the digestive system].
    Battocchio F; Negri L; Tacchettti G
    Clin Ter; 1979 Jun; 89(6):601-10. PubMed ID: 397029
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical trial of trimebutine (Mebutin) in spastic colon.
    Moshal MG; Herron M
    J Int Med Res; 1979; 7(3):231-4. PubMed ID: 456734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DA 3177 a new synthetic spasmolytic agent in the management of spastic-dyskinetic conditions of the digestive tract. Double-blind controlled clinical trial].
    Bonzi G; Reguzzoni G; Rocca F; Negri L
    Clin Ter; 1979 Apr; 89(2):187-96. PubMed ID: 385213
    [No Abstract]   [Full Text] [Related]  

  • 10. Double blind trial of trimebutine in the irritable bowel syndrome.
    Fielding JF
    Ir Med J; 1980 Oct; 73(10):377-9. PubMed ID: 7000730
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in the irritable colon: I. Administration by single i.v].
    Galeone M; Stock F; Moise G; Cacioli D; Benazzi E; Riva A
    Pharmatherapeutica; 1986; 4(7):445-56. PubMed ID: 3960945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative clinical study of the combination of clidinium(br)-chlordiazepoxide and trimebutine in the treatment of functional colopathies].
    Copé R
    Med Chir Dig; 1981; 10(8):713-7. PubMed ID: 6896078
    [No Abstract]   [Full Text] [Related]  

  • 13. Trimebutine, a new antispasmodic in the treatment of dyspepsia.
    Walters JM; Crean P; McCarthy CF
    Ir Med J; 1980 Oct; 73(10):380-1. PubMed ID: 7429788
    [No Abstract]   [Full Text] [Related]  

  • 14. The incidence, risk factors, and clinical outcomes of rhabdomyolysis associated with fenoverine prescription: a retrospective study in South Korea (1999-2014).
    Cho J; Na J; Bae E; Lee TW; Jang HN; Cho HS; Chang SH; Park DJ
    BMC Pharmacol Toxicol; 2020 Apr; 21(1):30. PubMed ID: 32334639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute rhabdomyolysis due to fenoverine].
    Hébuterne X; Chichmanian RM; Cohen HL; Rampal P
    Gastroenterol Clin Biol; 1991; 15(11):861-2. PubMed ID: 1769482
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative efficacy and safety of trimebutine versus mebeverine in the treatment of irritable bowel syndrome.
    Rahman MZ; Ahmed DS; Mahmuduzzaman M; Rahman MA; Chowdhury MS; Barua R; Ishaque SM
    Mymensingh Med J; 2014 Jan; 23(1):105-13. PubMed ID: 24584382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenoverine-induced rhabdomyolysis.
    Chariot P; Ratiney R; Le Maguet F; Fourestié V; Astier A; Gherardi R
    Hum Exp Toxicol; 1995 Aug; 14(8):654-6. PubMed ID: 7576832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research into individual predisposition to develop acute rhabdomyolysis attributed to fenoverine.
    Jouglard J; Kozak-Ribbens G; de Haro L; Cozzone PJ
    Hum Exp Toxicol; 1996 Oct; 15(10):815-20. PubMed ID: 8906430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute rhabdomyolysis and necrotizing enterocolitis after ingestion of fenoverine].
    Benamouzig R; Chaussade S; Roche H; Aubert A; Fiessinger JN; Carlet J; Dazza FE; Couturier D
    Gastroenterol Clin Biol; 1992; 16(8-9):719-20. PubMed ID: 1426831
    [No Abstract]   [Full Text] [Related]  

  • 20. Trimebutine: abuse, addiction and overdose.
    Prescrire Int; 2013 Oct; 22(142):241-2. PubMed ID: 24298588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.